Activation of endothelial cells in thrombosis and vasculitis

Scandinavian Journal of Rheumatology

Volumn 26, Issue 3, 1997, Pages 145-150

  Cockwell, P ^a   Tse, W Y ^a   Savage, C O S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Anti phospholipid antibodies; Systemic vasculitis; Thrombosis; Vascular endothelium

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE;

ANIMAL CELL; ANTIPHOSPHOLIPID SYNDROME; BLOOD VESSEL TONE; CELL MIGRATION; ENDOTHELIUM CELL; HEMOSTASIS; HOMEOSTASIS; HUMAN; INFLAMMATORY CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULITIS; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULITIS;

EID: 0030807514     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709065673     Document Type: Review

References (58)

1. Willms-Kretschmer K, Flax M H, Cotran R S. The fine structure of the vascular response in hapten specific delayed hypersensitivity and contact dermatitis. Lab Invest 1967;17:334-49
2. Pober J S. Cytokine mediated activation of vascular endothelium. Am J Pathol 1988;133:426-33
3. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51
4. Osborne L. Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6
5. Pearson JD. The control of production and release of haemostatic factors in the endothelial cell. Baillieres Clin Haematol 1993;6:629-51
6. Preissner KT. Biological relevance of the protein C system and laboratory diagnosis of protein C and protein S deficiencies. Clin Sci (Colcli) 1990;78:351-64
7. Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin-1. J Clin Invest 1986:78;587-91
8. Qi J, Kreuttzer D L. Fibrin activation of vascular endothelial cells; induction of IL-8 expression. J Immunol 1995;155:867-76
9. Ribes J, Feng N, Wagner D, Francis C W. Mediation of fibrin induced release of von Willebrand factor from cultured endothelial cells by fibrin B chain. J Clin Invest 1989;84:435-42
10. Bunce L, Sporn L, Francis C. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residue 15-42 of the β chain. J Clin Invest 1992;89:842-50
11. Hughes GRV. The antiphospholipid syndrome-10 years on. Lancet 1993;342:341-4
12. Horkko S, Miller E, Dudl E, Reaven P, Curtiss L K, Zvaifler N J, et al. Antiphospholipid antibodies are directed against epitopes of oxidised phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidised low density lipoprotein. J Clin Invest: 1996;98:815-25
13. Oosting J D, Derksen R H W M, Blokzijl L, Sixma JJ, de Groot PG. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity-studies in a thrombosis model. Thromb Haemost 1992;68:278-84
14. Borrel M, Sala N, de Castellarnau C, Lopez S, Gari M, Fontcuberta J. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of Factor Va by activated Protein C on human endothelial cells. Thromb Haemost 1992;68:268-72
15. Angles-Cano E, Sultan Y, Clauvel J P. Predisposing factors to thrombosis in systemic lupus erythematosus. J Lab Clin Med 1979;94:312-23
16. Carreras L O, Machin S J, Deman R, Defryn G, Vermylen J, Spitz B, et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981;I:244-6
17. Lindsey NJ, Henderson FI, Malia R, Milford-Ward MA, Greaves M, Hughes P. Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosisprone paients with systemic lupus erythematosus with the antiphospholipid syndrome. B J Rheumatol 1994;33:20-26
18. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, et al. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematous. Clin Exp Immunol 1988;74:247-53
19. Hasselaar P, Derksem RHWM, Blokzijl L, de Groot PG. Cross reactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 190;63:169-73
20. Hill MB, Phipps JL, Malia RG, Greaves M, Hughes P. Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS). Clin Exp Immunol 1995;102:368-7
21. McRae KR, DeMichele A, Samuel P, Roth D, Kuo A, Meng Q-H, et al. Detection of endothelial cell reactive immunoglobulin in patients with antiphospholipid antibodies. Br J Haematol 1991;79:595-605.
22. Springer TA. Traffic signals for lymphocyte recirculation and leucocyte emigration: The multistep paradigm. Cell 1994;76:301-14
23. Lasky LA. Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964-9
24. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of inducible endothelial-leucocyte adhesion molecule. Pro Natl Acad Sci USA 1987; 84:9238-42
25. Shimizu Y, Shaw S, Graber N, Venkat Gopal T, Horgan K, Van Seventer A, et al. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature 1991;349:799-802
26. Jutila MA, Bargatze RF, Kurk S, Warnock RA, Ehsani N, Watson SR, et al. Cell surface P- and E-Selectin support shear-dependent rolling of bovine γ/δ T cells. J Immunol 1994;153:3917
27. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Ann Rev Immunol 1992; 10:561-91
28. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 1993;11:767-84
29. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon γ: tissue distribution, biochemistry and function of natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54
30. Arnaout MA. Structure and function of the leukocyte adhesion molecule CD11/CD18. Blood 1990;75:1037
31. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule-1, a cytokine induced endothelial cell protein that binds to lymphocytes. Cell 1989;59:1203-11
32. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, et al. VCAM-1 on activated endothelium interacts with the leukocyte intergrin VLA-4 at a distinct site from the VLA-4/fibronectin binding site. Cell 1990;60:577-84
33. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994;55:97-179
34. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial clls present adhesion inducing cytokines to leukocytes. Immunol Today 1993;14:111-115
35. Adu D, Howie AJ, Scott DGI, Bacon PA, McGonigle RJS, Michael J. Polyarteritis and the kidney. Q J Med 1987;62:221-37
36. Weiss MA, Crissman JD. Renal biopsy findings in Wegener's Granulomatosis: Segmental necrotizing glomerulonephritis with glomerular thrombosis. Hum Pathol 1984;15:943-56
37. Antonyvych TT, Sabnis SG, Tuur SM, Sesterhenn IA, Balow JE. Morphological differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques. Mod Pathol 1989;2:349
38. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7
39. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987;1:89-93
40. Falk RJ, Terrel RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vivo. Proc Natl Acad Sci USA 1990;87:4115-9
41. Savage COS, Pottinger BE, Gaskin G, Pusey CD and Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase-3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-42
42. Savage COS, Gaskin G, Pusey CD, Pearson JD. Anti-neutrophil cytoplasmic antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol 1993;1:190-5
43. Varganum M, Adu D, Taylor CM, Michael J, Richards N, Neuberger J, et al. Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis. Nephrol Dial Transplant 1992;7:1077-81
44. Savage COS, Pottinger BE, Gaskin G, Lockwood CM, Pusey CD and Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1991;85:14-9
45. Del Papa N, Meroni PL, Barcellini W, Sinico A, Radice A, Tincani A, et al. Antibodies to endothelial cells in primary vasculitides mediate in vitro cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992;63:267-74
46. Mayet WJ, Csernock E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde K-H. Human endothelial cells express proteinase-3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993;82:1221-9
47. Mayet W J, Schwarting A, Meyer Zum Bushenfelde K H. Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin Exp Immunol 1994;97:458-65
48. King WJ, Adu D, Daha MR, Brooks CJ, Radford DJ, Pall AA, et al. Endothelial and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 1995;102:98-105.
49. Bradley J R, Lockwood C M, Thiru S. Endothelial cell activation in patients with systemic vasculitis. Q J Med 1994;87:741-5
50. Pall AA, Howie AJ, Adu D, Richards GM, Inward CD, Milford DV et al. Glomerular VCAM-1 expression in renal vasculitis. Nephrol Dial Transplant 1994;9:897
51. Mayet WJ. Meyer zum Buschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993;94:440-6
52. Seron D, Cameron JS and Haskard DO. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 1991;6:917-22
53. Noronha I L, Kruger C, Andrassy K, et al. In situ production of TNFα, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-92
54. Rovin B H, Rumancik M, Tan L, Dickerson J. Glomerular expression of Monocyte Chemoattractant Prolein-1 in experimental and human glomerulonephritis. Lab Invest 1994;71:536-42
55. Cockwell P, Howie AJ, Adu D, Savage COS. In situ analysis of chemokine mRNA in glomerulonephritis. J Am Soc Nephrol 1996;7:1694
56. Kekow J, Symkowiak CH, Gross WL. Involvement of cytokines in granuloma formation within primary systemic vasculitis. In Romagni S (ed) Cytokines: basic principles and clinical applications. New York: Raven Press, 1992:341-8.
57. Hergesell O, Andrassy K, Nawroth P, Gabat S. Endothelial dysfunction and activation of haemostasis (anticardiolipin antibodies, thrombin-antithrombin complexes (TAT), prothrombin fragments (F1 + 2), D-Dimers) as markers of disease activity in patients with systemic necrotizing vasculitis. Thromb Haemost 1993;69:953
58. Pall AA, Adu D, Wilde JT, Roper J, George J, Richards NT et al. Prothrombotic tendency in systemic vasculitis. Nephrol Dial Transplant 1994;9:941